President Bola Tinubu has congratulated the National Agency for Food and Drug Administration and Control (NAFDAC) on retaining the World Health Organisation’s Maturity Level 3 (ML3) status for regulating medicines and vaccines. The achievement follows a WHO re-benchmarking exercise in May 2025, confirming NAFDAC’s continued compliance with globally recognized standards.
Nigeria first attained ML3 status in 2022, becoming the first non-vaccine-producing African nation to reach this milestone. Tinubu commended NAFDAC’s professionalism, dedication, and contribution to public health, noting that the recognition strengthens Nigeria’s role in global health security and pandemic preparedness.
The President highlighted that the feat aligns with his Renewed Hope Agenda, which includes upgrading over 17,000 primary health centres, improving maternal care, training 120,000 health workers, and doubling national health insurance coverage in three years. He reaffirmed his administration’s commitment to ensuring the safety, quality, and efficacy of medicines and vaccines, while expanding local manufacturing and fostering investment in the pharmaceutical sector.
